Beaune P - Search Results

1

Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.

Lecomte T, Ferraz JM, Zinzindohoué F, Loriot MA, Tregouet DA, Landi B, Berger A, Cugnenc PH, Jian R, Beaune P, Laurent-Puig P. Lecomte T, et al. Among authors: beaune p. Clin Cancer Res. 2004 Sep 1;10(17):5880-8. doi: 10.1158/1078-0432.CCR-04-0169. Clin Cancer Res. 2004. PMID: 15355920

2

Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.

Ferraz JM, Zinzindohoué F, Lecomte T, Cugnenc PH, Loriot MA, Beaune P, Stücker I, Berger A, Laurent-Puig P. Ferraz JM, et al. Among authors: beaune p. Int J Cancer. 2004 Jun 10;110(2):183-7. doi: 10.1002/ijc.20124. Int J Cancer. 2004. PMID: 15069679

3

Glutathione S-transferase P1 polymorphism (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy.

Lecomte T, Landi B, Beaune P, Laurent-Puig P, Loriot MA. Lecomte T, et al. Among authors: beaune p. Clin Cancer Res. 2006 May 15;12(10):3050-6. doi: 10.1158/1078-0432.CCR-05-2076. Clin Cancer Res. 2006. PMID: 16707601

4

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

Lecomte T, Berger A, Zinzindohoué F, Micard S, Landi B, Blons H, Beaune P, Cugnenc PH, Laurent-Puig P. Lecomte T, et al. Among authors: beaune p. Int J Cancer. 2002 Aug 10;100(5):542-8. doi: 10.1002/ijc.10526. Int J Cancer. 2002. PMID: 12124803

5

Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.

Blons H, Gad S, Zinzindohoué F, Manière I, Beauregard J, Tregouet D, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P. Blons H, et al. Among authors: beaune p. Clin Cancer Res. 2004 Apr 15;10(8):2594-9. doi: 10.1158/1078-0432.ccr-1116-03. Clin Cancer Res. 2004. PMID: 15102660

6

Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ?

Gad S, Teboul D, Lièvre A, Goasguen N, Berger A, Beaune P, Laurent-Puig P. Gad S, et al. Among authors: beaune p. BMC Cancer. 2004 Jul 9;4:31. doi: 10.1186/1471-2407-4-31. BMC Cancer. 2004. PMID: 15245581 Free PMC article.

7

Clinical value of mitochondrial mutations in colorectal cancer.

Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, Arnould L, Beaune P, Faivre J, Laurent-Puig P. Lièvre A, et al. Among authors: beaune p. J Clin Oncol. 2005 May 20;23(15):3517-25. doi: 10.1200/JCO.2005.07.044. J Clin Oncol. 2005. PMID: 15908662

8

[Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].

Loriot MA, Beaune P. Loriot MA, et al. Among authors: beaune p. Rev Prat. 2007 Jun 30;57(12):1281-6. Rev Prat. 2007. PMID: 17717937 Review. French.

9

Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.

Boige V, Mendiboure J, Pignon JP, Loriot MA, Castaing M, Barrois M, Malka D, Trégouët DA, Bouché O, Le Corre D, Miran I, Mulot C, Ducreux M, Beaune P, Laurent-Puig P. Boige V, et al. Among authors: beaune p. J Clin Oncol. 2010 May 20;28(15):2556-64. doi: 10.1200/JCO.2009.25.2106. Epub 2010 Apr 12. J Clin Oncol. 2010. PMID: 20385995 Clinical Trial.

10

Pharmacogenetics of oral anticoagulants: the opportunity for individualized drug treatment of greater safety.

Loriot MA, Beaune P. Loriot MA, et al. Among authors: beaune p. Per Med. 2007 Nov;4(4):413-421. doi: 10.2217/17410541.4.4.413. Per Med. 2007. PMID: 29793282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters